Crowdonomics
Labwire Inc

Reg A+ · Equity · Apr 2023

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $16M max
0% of ceiling
Investors
—
—
Estimated pre-money
$2.2M
—

Financials disclosed in this offering

FY2022 · hover for source
$0
−$23K
FY2022
RevenueNet income
Metric
FY2022 unaudited
Income statement
Revenue
$0
Cost of goods sold
$0
Net income
-$22,754
Balance sheet
Cash
$0
Accounts receivable
$0
Total assets
$0
Long-term debt
$0
Total liabilities
$22,754
Other
Headcount
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Jun 15, 2023
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  2. Jun 5, 2023
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  3. May 18, 2023
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$2.2M
Price / share$0.0125
Shares offered800,000,000

Estimated, not stated: $0.0125 × 179,199,001 securities outstanding.

Offering details

Target—
Max$16,000,000
Min investment—
OpenedApr 21, 2023
Deadline—
Days active1,268

Links & provenance

Source: SEC EDGAR
0001376474-23-000253
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.